Document:

EX-4.1

 Exhibit 4.1 

TRINITY BIOTECH PLC 

EMPLOYEE SHARE OPTION PLAN 2013 

 TRINITY BIOTECH PLC 

EMPLOYEE SHARE OPTION PLAN 2013 

Rules 
 Definitions

  

	1.	The Plan is established by an ordinary resolution of the Shareholders passed on 24 May 2013. The purpose of the Plan is to provide for the granting of share options to Directors and Employees of and Consultants to
the Company and its subsidiary and associated companies in accordance with the provisions hereinafter contained. 

  

	2.	In the Plan the following expressions bear the following meanings:- 

  

					
	(a)	  	“Associated Company”	  	means a company under the Control of the Company or any Subsidiary of the Company or any combination thereof or in which the Company and/or its Subsidiaries have a shareholding interest of 20% or greater;
			
	(b)	  	“the Board”	  	means a duly constituted committee of the Board of Directors for the time being of the Company at which a quorum is present;
			
	(c)	  	“the Company”	  	means Trinity Biotech Public Limited Company;
			
	(d)	  	“Consultant”	  	means any individual or company who has a consultancy agreement with the Company or a Participating Company;
			
	(e)	  	“Control”	  	has the same meaning as in Section 11 of the Taxes Consolidation Act, 1997;
			
	(f)	  	“Date of Grant”	  	means the date on which an Option is granted as determined by the Board and specified in the Option Certificate;
			
	(g)	  	“Directors”	  	means in relation to the Company or a Participating Company its board of directors and “Director” shall be construed accordingly and shall include non-executive members of any such board of directors;
			
	(h)	  	“Employee”	  	means an employee of the Company or a Participating Company (other than one who is a Director of the Company or of a Participating Company);
			
	(i)	  	“Final Option Date”	  	means in relation to an Option the last date upon which any part thereof may be exercised under Clause 7, which date shall be determined by the Board and specified in the Option Certificate, but in no event shall be later than the
date preceding the tenth anniversary of the Date of Grant;

  
 2 

					
			
	(j)	  	“Market Value”	  	means the price which in the opinion of the Board represents the fair market value of a Share, having regard in circumstances where the Shares are traded on the Markets, to the prices prevailing in the Markets;
			
	(k)	  	“Markets”	  	the Stock Exchange Official List – Ireland and the National Association of Security Dealers Automated Quotation Market;
			
	(l)	  	“Nominated Person”	  	means a person who shall have been nominated for the purpose of the Plan pursuant to Clause 3(a);
			
	(m)	  	Notice of Exercise”	  	means a notice of exercise of an Option in the form set out in Schedule 2 to the Plan or such other form approved by the Board;
			
	(n)	  	“Option”	  	means an option granted pursuant to the Plan;
			
	(o)	  	“Option Certificate”	  	means a certificate executed under the seal of the Company evidencing the grant of an Option, in the form set out in Schedule 1 to the Plan or such other form approved by the Board;
			
	(p)	  	“Option Price”	  	means the price at which a Share must be subscribed on exercise of an Option;
			
	(q)	  	“Participant”	  	means any Nominated Person (or, in the event of his death, his personal representative) who is for the time being the holder of an Option;
			
	(r)	  	“Participating Company”	  	means any company being the Company or an Associated Company to whom the Board has extended the Plan;
			
	(s)	  	“the Plan”	  	means the Trinity Biotech Plc Employee Share Option Plan 2013, consisting of these rules, as amended from time to time in accordance with the provisions in that regard herein contained;
			
	(t)	  	“Shares”	  	means the “A” Ordinary Shares of US$0.0109 each in the capital for the time being of the Company; and
			
	(u)	  	“Subsidiary”	  	has the meaning assigned in Section 155 of the Companies Act 1963.

 The Rule headings are for ease of reference only and shall not in any way affect the interpretation hereof. 

  
 3 

 ELIGIBILITY FOR PARTICIPATION 

 

					
	3.	 	(a)	  	Power of Board

 The Plan is available for Directors, Employees or Consultants who shall be nominated for the purpose by the
Board. 
  

					
		 	(b)	  	Absolute Discretion

 The Board shall at its absolute discretion determine whether or not a person is a Director, Employee or
Consultant. 
  

					
		 	(c)	  	No Right 

 No person shall be entitled as of right to participate in the Plan and the decision as to who shall have the
opportunity of participating and the extent of his participation will, subject to the Plan, be made by the Board at its absolute discretion. 

LIMITS 
  

					
	4.	 	(a)	  	Ten Year Limit 

 No Option shall be granted under the Plan on a date later than ten years after the date of adoption of the Plan
by the members of the Company. 
  

					
		 	(b)	  	Overall Limits for Plan at Adoption Date

 Subject to Rules 13 and 14, the maximum number of Shares over which Options may be in issue at any one time
under the Plan shall be 6,000,000. 
  

					
	5.	 	(a)	  	Power to Grant

 Subject to the provisions of paragraph (e) of this Rule 5 and Rule 21(a), the Board may on behalf of the
Company grant Options to Nominated Persons at any time or times within ten years of the date of adoption of this Plan by the members of the Company. 
  

					
		 	(b)	  	Non-Assignable

 Options shall be personal to the grantee and non-assignable, subject to Rule 8, unless the Board in its sole
discretion consents to an assignment or transfer. Any purported transfer, assignment, mortgage or charge of an Option, without the consent in writing of the Board, shall cause the Option to lapse forthwith. 

 

					
		 	(c)	  	Certificates

 An Option Certificate shall be issued to a Participant in respect of each Option. 

  
 4 

					
		 	(d)	  	Right to Renounce

 An individual to whom an Option has been granted may, by notice in writing within 30 days after receipt of the
Option Certificate, renounce such Option, in which event it shall be deemed never to have been granted. 
  

					
		 	(e)	  	Employee with Two Years to Retire

 An Option shall not be granted to any person who would otherwise have been eligible under Rule 3(a) if such
person is within two years of the date upon which he would normally be expected to retire. 
 OPTION PRICE 

 

	6.	The Option Price in relation to an Option shall be determined by the Board but shall not be less than the nominal value of a Share. If the option is to be granted at Market Value the Market Value per Share of the Shares
comprised in the Option is to be computed as at the day prior to the Date of Grant. 

 PERIODS FOR EXERCISE OF OPTIONS

  

					
	7.	 	(a)	  	Subject to Rules 7(b), 8, 9, 10 and 16, an Option may be exercised at any time or times prior to the Final Option Date. An Option shall expire immediately after the Final Option Date to the extent that it has not been
exercised.
			
		 	(b)	  	The Board may when it grants an Option at its entire discretion attach a condition thereto such that the Option or portion(s) thereof may not be exercised until a period(s) (not exceeding four years) has elapsed from the Date of
Grant. Such vesting condition(s) will be set out in the Option Certificate.

 DEATH AND TRANSFER OF RIGHTS 
  

					
	8.	 	(a)	  	In the event of the death of a Participant before the Final Option Date the personal representative of such deceased Participant may, at any time and from time to time but no later than one year after the date of such death (or, if
earlier, the Final Option Date), exercise the Option, to the extent exercisable on the date of the Participant’s death, in whole or in part. Upon the expiration of such period the Option shall lapse to the extent that it shall not have been so
exercised.
			
		 	(b)	  	To the extent an Option is not exercisable on the date of a Participant’s death, the Option shall lapse on such date unless the Board in its sole discretion determines that such Option shall be exercisable in whole or in part
after such date and if the Board does so determine, the Option shall be exercisable in accordance with Rule 8(a).

  
 5 

 RETIREMENT, RESIGNATION ETC. 

 

							
	9.	 	(a)	  	If a Participant ceases to be an Employee or Director or Consultant on account of:-
				
		 		  	(i)	  	retirement at normal retirement age; or
				
		 		  	(ii)	  	resignation or early retirement due to disability or ill-health (such matter to be determined by the Board in its absolute discretion);
			
		 		  	the Participant may at any time and from time to time but no later than one year after he shall have so resigned or retired (or, if earlier, the Final Option Date), exercise the Option, to the extent exercisable on the
date of such resignation or retirement, in whole or in part. Upon the expiration of such period the Option shall lapse to the extent that it shall not have been so exercised.
			
		 	(b)	  	To the extent an Option is not exercisable as of the date of a Participant’s resignation or retirement as described in Rule 9(a), the Option shall lapse on such date unless the Board in its sole discretion
determines that such Option shall be exercisable in whole or in part after such date and if the Board does so determine, the Option shall be exercisable in accordance with Rule 9(a).
			
		 	(c)	  	If a Participant ceases on account of resignation, retirement, dismissal or otherwise (except on death, retirement at normal retirement age or resignation or early retirement due to disability or ill-health) to be an
Employee or Director or Consultant, each Option held by the Participant, to the extent not exercisable at the date of such cessation, shall lapse on such date. To the extent an Option is exercisable at the date of such cessation, it may be exercised
by the Participant in whole or in part within 90 days after such date (or, if earlier, until the Final Option Date), failing which it will lapse.
			
		 	(d)	  	If a Participant’s employment or office or consultancy is terminated summarily for serious misconduct by the Company or Participating Company employing or engaging him, each Option held by the Participant shall
lapse in full immediately upon such termination.
			
		 	(e)	  	Notwithstanding the foregoing provisions, the Board in its sole discretion may determine that if circumstances so warrant, an Option may be exercised after the Participant ceases to be an Employee, Director or Consultant
during a longer period than the period provided under the foregoing provisions and/or that an Option, to the extent not exercisable on the date a Participant ceases to be an Employee, Director of Consultant, shall be exercisable in full or in part
after such cessation and may be exercised within a period specified by the Board, but in no event may an Option be exercised later than the Final Option Date and an Option will lapse to the extent not exercised within the period specified by the
Board.
			
		 	(f)	  	In no circumstances shall any Participant who ceases to serve as an Employee or Director or Consultant be entitled to any compensation for any loss of any right or benefit or prospective right or benefit under the Plan
which he might otherwise have enjoyed whether such compensation is claimed by way of damages for wrongful dismissal or other breach of contract or by way of compensation for loss of office or otherwise howsoever.

  
 6 

 MERGER OR TAKEOVER 

 

	10.	In the event that the Company is a party to a merger, takeover or other reorganisation, including but not limited to a court sanctioned compromise or scheme arrangement, pursuant to which a party or parties acting in
concert obtain(s) Control of the Company, or the Board considers that this is about to occur, or notice is given of a resolution for the voluntary winding-up of the Company, each Option shall automatically accelerate and become exercisable in full
as of a date specified by the Board, conditional upon such merger, takeover or other reorganisation or winding-up, and the Board shall, at its discretion, with respect to each Option: 

 

	 	(i)	request the Participant to exercise the Option within such period and subject to such conditions as the Board may at its discretion determine and if the Participant does not comply with such request the Option shall
lapse on a date specified by the Board; or 

  

	 	(ii)	arrange for payment of a cash settlement to the Participant, in cancellation of the Option, equal per Share subject to the cancelled Option to the excess of the amount to be paid for a Share in the merger or takeover or
reorganisation or winding up over the Option Price. 

 PROCEDURES ON EXERCISE OF OPTIONS 

 

	11.	Upon the exercise of an Option in whole or in part the Participant shall deliver a Notice of Exercise and pay the Option Price in respect of the Shares for which the Option is being exercised to the Company, in cash or
by cheque or by same-day sale exercise through a broker designated by the Company, or by any other means approved by the Board, and shall deliver the Option Certificate to the Company and the Company shall issue the appropriate Shares to the
Participant and deliver to the Participant any appropriate balance Option Certificate. 

  

	12.	All Shares issued on any exercise of an Option shall rank pari passu in all respects with the Shares already in issue. 

BONUS, RIGHTS ISSUES, VARIATION IN SHARE CAPITAL 
  

	13.	If an allotment of Shares is made to the holders of Shares credited as fully paid up and by way of capitalisation of reserves or a consolidation or subdivision or a reduction of the share capital of the Company or if
any other variation in the share capital of the Company occurs, the Board may make such adjustment to the Option Price and/or the number and/or class of Shares subject each Option and to the share limit set out in Rule 4(b) as it deems appropriate.

  

	14.	 If holders of Shares are granted rights to subscribe for further shares (such rights being related to the number of Shares held by them respectively)
the Board shall at its absolute discretion decide whether the granting of such rights and the subscriptions made thereunder 

  
 7 

	 	
shall result in the depletion in the value of each Share and the Board may make such adjustment(s) to the Option Price and/or the number and/or class of Shares subject each Option and to the
share limit set out in Rule 4(b) as it deems appropriate. 

 NO SHARE ISSUES AT A DISCOUNT 

 

	15.	Notwithstanding anything herein contained no Option shall be granted to subscribe for any Shares at a discount to the nominal value of the Shares. 

LIQUIDATION 
  

	16.	In the event of a liquidator being appointed to the Company all Options shall ipso facto cease to be exercisable and (save to the extent, if at all, that the Board may prior to such liquidation at its absolute
discretion determine) Participants shall not be entitled to damages or other compensation of any kind. 

 EXCHANGE
QUOTATIONS 
  

	17.	The Company will within five working days after the exercise of an Option apply for permission to deal in the Shares or securities of the Company (whichever one traded) issued pursuant to the exercise of Options on
NASDAQ or such other stock exchange upon which the Shares or securities are for the time being quoted. 

 ALTERATIONS

  

	18.	The Company may at any time by resolution of the Board vary, amend or revoke any of the provisions of the Plan in such manner as it considers fit. 

OBLIGATION TO KEEP UNISSUED CAPITAL 
  

	19.	The Company shall keep unissued sufficient Shares to enable it to discharge its obligations under the Plan and take all necessary steps (including the passing of resolutions of the Company) to ensure that the directors
of the Company shall, at all times, be generally and unconditionally authorised to allot Shares pursuant to Options to Nominated Persons in accordance with the provisions of Section 20 Companies (Amendment) Act, 1983 or any statutory
modification or re-enactment thereof, and so that the provisions of Section 23 of the said Act, or any statutory modification or re-enactment thereof shall not apply to any such allotment. 

  
 8 

 TERMINATION 
  

					
	20.	 	(a)	  	The Plan may be terminated at any time by resolution of the Board.
			
		 	(b)	  	Subsequent to any termination of the Plan under paragraph (a) of this Rule 20 the Company shall not grant any further Options but no such termination shall affect or modify any subsisting rights or obligations of Participants
in respect of any Options and notwithstanding such termination the Company shall continue to administer and manage the Plan in accordance with the Rules.

 GENERAL 
  

					
	21	 	(a)	  	If the Shares are listed on a stock exchange or securities market, the Company and each Participant shall be subject to such insider dealing policy as the Company may implement from time to time for its officers and employees
imposing restrictions on transactions in the Shares during specified periods.

  

	 	(b)	In the event of any dispute or disagreement as to the interpretation of the Plan, or as to any question or right arising from or related to the Plan, the decision of the Board shall be final and binding upon all
persons. 

  

	 	(c)	Any notice or other communication under or in connection with an Option and/or the Plan may be given by personal delivery or by sending the same by prepaid post, in the case of the Company to: 

The Share Option Plan Administrator 

Trinity Biotech Plc 
 IDA Business
Park 
 Bray 
 Co. Wicklow 

and, in the case of a Nominated Person or a Participant, to his last known address provided to the Company, or to the address of the place of
business at which he performs the whole or substantially the whole of the duties of his employment or engagement, and where a notice or other communication is personally delivered, it shall be deemed to have been received at the time of delivery and
where it is posted to an address within Ireland, it shall be deemed to have been received forty-eight (48) hours after it was put into the post properly addressed and stamped and where it is posted to an address outside Ireland, it shall be
deemed to have been received on the fifth business day after the date it was put into the post properly addressed and stamped. If a Participant is an employee and is not on extended leave from employment, notice to such Participant may be sent by
email to the address at the Company or the Participating Company at which the Participant customarily receives email correspondence in connection with his employment and shall be deemed to have been received upon transmission. 

 

	 	(d)	The Board shall be entitled to authorise any person to execute on behalf of a Participant, at the request of the Participant, any document relating to the Plan, insofar as such document is required to be executed
pursuant thereto. 

  
 9 

	 	(e)	If withholding tax obligations arise in connection with any transaction under the Plan, then the Participant or other person who is subject to such obligations shall make arrangements satisfactory to the Company to meet
such obligations. The Company shall not be required to issue or procure the transfer of any Shares under the Plan until such obligations are satisfied. 

  

	 	(f)	By participating in the Plan, each Participant consents to the holding and processing of personal data relating to him by the Company or any Participating Company for all purposes relating to the operation of the Plan
which purpose include, but are not limited to: 

  

	 	(i)	administering and maintaining Participant records; 

  

	 	(ii)	providing information to tax and regulatory authorities; 

  

	 	(iii)	providing information to registrars, brokers and other third party administrators of the Plan; and 

  

	 	(iv)	providing information, on a confidential basis, to potential purchasers of the Company or the business in which the Participant is employed. 

 

	 	(g)	The Plan shall be governed by and construed and interpreted in accordance with Irish law and the Company and Participants agree to submit to the non-exclusive jurisdiction of the Courts of Ireland in relation to any
claim, dispute or difference which may arise hereunder. 

  
 10 

 SCHEDULE 1 

OPTION CERTIFICATE 

TRINITY BIOTECH PLC EMPLOYEE SHARE OPTION PLAN 2013 

THIS DOCUMENT IS IMPORTANT 
  

					
	Name of Participant:	 	  
	 	
			
	Address of Participant:	 	  
	 	
			
		 	  
	 	
			
		 	  
	 	
			
		 	  
	 	
			
	Date of Grant:	 	  
	 	
			
	Number of Shares:	 	  
	 	
			
	Option Price per Share:	 	  
	 	
			
	Vesting Conditions:	 	  
	 	
			
	Last Date on which Notice of Exercise of Option can be given (Final Option Date):	 	  
	 	

 THIS IS TO CERTIFY that the Participant named above was on the above Date of Grant granted an option to
subscribe for the above number of “A” Ordinary Shares (“Shares”) in Trinity Biotech plc (the “Company”) at the above Option Price per Share. This Option may not be transferred, assigned, mortgaged or charged by the
Participant and any purported transfer, assignment, mortgage or charge will cause this Option to lapse forthwith. This Option is exercisable subject to and in accordance with the terms and conditions of the Trinity Biotech plc Plan 2013, a copy of
which accompanies this Option Certificate. 
 If the Participant wishes to renounce this Option, he may do so by notifying the Company in writing by 30 days
after date of delivery of Option Certificate. 
 Please note that each employee is entirely responsible for the declaration and payment of tax on any
profits which may arise from the exercise of share options. The company accepts no liability whatsoever in relation to the payment of tax in this regard. 

  
 11 

					
	 PRESENT when the common seal
 of TRINITY BIOTECH
PUBLIC LIMITED COMPANY was affixed hereto:
	 		 	  

		 		 	Signature
			
		 		 	  

		 		 	Print name
			
		 		 	  

		 		 	Signature
			
		 		 	  

		 		 	Print name

  
 12 

 SCHEDULE 2 

NOTICE OF EXERCISE 
  

			
	TO:	  	The Secretary
		  	Trinity Biotech plc
		  	IDA Business Park
		  	Bray
		  	Co. Wicklow

 Trinity Biotech plc (“The Company”) 

Trinity Biotech plc Employee Share Option Plan 2013 

Date of Grant of Option: 
 Option Price per Share: 

Total number of Shares subject to Option: 
 I hereby exercise
the above option in respect of             ** Ordinary Shares in the Company. 
 I
enclose payment of the Option Price by [cheque][cash][cashless exercise][other method of payment]. 
  

			
	Full Name:	 	  

		
	Address:	 	  

		
	Signature:	 	  

		
	Date:	 	  

 **Note 
 Insert the
number of Shares in respect of which the option is exercised. 

  
 13EX-4.2

 Exhibit 4.2 

TRINITY BIOTECH PUBLIC LIMITED COMPANY 

- and - 
 WILLIAM J. MAGGIO 

SHARE OPTION AGREEMENT 

William Fry 
 Solicitors 

Fitzwilton House 
 Wilton Place 

Dublin 2 
 www.williamfry.ie 

© William Fry 2013 

014601.0004 

 TABLE OF CONTENTS 

 

							
	1.	 	DEFINITIONS	  	 	3	  
			
	2.	 	GRANT OF OPTION	  	 	4	  
			
	3.	 	OPTION PRICE	  	 	4	  
			
	4.	 	PERIOD FOR EXERCISE OF OPTION	  	 	4	  
			
	5.	 	PROCEDURE ON EXERCISE OF OPTION	  	 	4	  
			
	6.	 	ADJUSTMENTS TO SHARE CAPITAL	  	 	4	  
			
	7.	 	SHARE CAPITAL	  	 	5	  
			
	8.	 	MERGER OR TAKEOVER	  	 	5	  
			
	9.	 	RESTRICTION ON SALE	  	 	5	  
			
	10.	 	LIQUIDATION	  	 	6	  
			
	11.	 	CONSENT TO DATA PROCESSING	  	 	6	  
			
	12.	 	GENERAL PROVISIONS	  	 	6	  
		
	SCHEDULE 1	  	 	9	  
		
	SCHEDULE 2	  	 	10	  

  
 2 

			
	THIS AGREEMENT is made on	  	July 2013

  

			
	BETWEEN:	  	
		
		  	TRINITY BIOTECH PUBLIC LIMITED COMPANY
		  	 having its registered office at
		  	 IDA Business Park,
		  	 Bray, Co. Wicklow
		  	 (hereinafter called the “Company”)
		
		  	 - and -

		
		  	 WILLIAM J. MAGGIO
		  	 of 22 Linden Avenue, Buffalo NY 14214
		  	 (hereinafter called the “Optionholder”)

 WHEREAS: 
  

	 	A.	The Optionholder is an employee of IMMCO Diagnostics, Inc., a Delaware corporation under registered number 4457503 and a Subsidiary of the Company (as defined below). 

 

	 	B.	The parties have now agreed that the Optionholder shall be granted an option to subscribe for Shares (as hereinafter defined) in the capital of the Company on the terms and conditions hereinafter contained.

 IT IS AGREED as follows: 
  

	1.	Definitions 

 In this Agreement the following expressions shall have the following
meaning unless the context otherwise requires: 
 “Associated Company”, means a company under the Control of the Company or
any Subsidiary of the Company or any combination thereof or in which the Company and/or its Subsidiaries have a shareholding interest of 20% or greater; 

“Board”, the board of directors of the Company; 

“Control”, has the same meaning as in Section 11 of the Taxes Consolidation Act, 1997; 

“Restricted Shares”, means any Shares allotted to the Optionholder following an exercise of the Option in accordance with the
terms of this Agreement; 
 “Notice of Exercise”, means a notice of exercise of an Option in the form set out in Schedule 2
or such other form approved by the Board; 
 “Option”, the option granted pursuant to clause 2; 

“Option Certificate”, means a certificate executed under the seal of the Company evidencing the grant of an Option, in the
form set out in Schedule 1 hereto or such other form as may be approved by the Board; 
 “Option Price”, means the price per
Option Share specified in Clause 3; 
 “Option Shares”, subject to Clause 6, 102,400 A Shares (25,600 ADRs); 

“Grant Date”, the date of this Agreement; 

  
 3 

 “Scheduled Termination Date”, 3 December 2017; 

“Shares”, means the “A” Ordinary Shares of $0.0109 each in the capital for the time being of the Company; and 

“Subsidiary”, has the meaning assigned in Section 155 of the Companies Act 1963. 

 

	2.	Grant of Option 

  

	 	(a)	In consideration of the entry by the Optionholder into this Agreement and of the payment of the sum of €1.00 now made by the Optionholder to the Company (the receipt of which the Company hereby acknowledges) and
subject to clauses 4, 6, 8 and 9, the Company hereby grants to the Optionholder an option to subscribe for and be allotted the Option Shares (the “Option”) subject to the due exercise of the Option in accordance with terms and conditions
of this Agreement. 

  

	 	(b)	An Option Certificate shall be issued to the Optionholder in respect of the Option on the Grant Date. 

  

	3.	Option Price 

 The Option Price payable upon exercise of the Option to subscribe for and
be allotted the Option Shares shall be $1.66 per Option Share ($6.64 per ADR). 
  

	4.	Period for exercise of Option 

 The Option shall be exercisable at any time or times
prior to the Scheduled Termination Date. The Option shall expire at 6p.m. on the Scheduled Termination Date to the extent that it has not been exercised prior to that date. 
  

	5.	Procedure on exercise of Option 

  

	 	(a)	The Option shall be exercised by notice in writing given by the Optionholder to the Company in the form set out in Schedule 2. The Optionholder shall notify the Company that he is exercising the Option in respect of all
or part of the Option Shares for the time being comprised in the Option and of the number of Option Shares in respect of which he is exercising the Option. The notice of exercise of the Option shall be accompanied by payment of the Option Price for
the Option Shares in respect of which the Option is exercised and the Option Certificate. The Option Price can be paid in cash or by cheque or by same-day sale exercise through a broker designated by the Company or any other means approved by the
Board. 

  

	 	(b)	As soon as practicable after receipt by the Company of such notice and receipt of payment of the Option Price, subject to the Company obtaining any regulatory or stock exchange consent which is necessary to enable it to
allot Option Shares pursuant to the exercise of the Option and subject to the terms of any such consent, the Option Shares shall be issued by the Company to the Optionholder and the Company shall deliver to the Optionholder any appropriate balancing
Option Certificate. 

  

	 	(c)	Save for the restrictions set out in Clause 9, all Shares issued on any exercise of the Option shall rank pari passu in all respects with the Shares already in issue. 

 

	6.	Adjustments to share capital 

 In the event of any variation in the Company’s
capital structure, whether by way of a rights issue, capitalisation of profits or reserves or any consolidation or subdivision or reduction of the capital of the Company, the number of Option Shares and / or the Option Price for each of those Shares
and/or the class of Option Shares shall be adjusted in such manner as the Board considers to be fair and reasonable. 

  
 4 

	7.	Share capital 

 The Company shall keep sufficient Shares to enable it to discharge its
obligations under this Agreement and shall take all steps as may be necessary (including the passing of any resolutions of the Company) to ensure that the directors of the Company shall, at all times, be generally and unconditionally authorised to
allot Shares to the Optionholder in accordance with the provisions of Section 20 of the Companies (Amendment) Act, 1983 or any statutory modification or re-enactment thereof and so that the provisions of Section 23 of the said Act (or any
such modification or re-enactment thereof) shall not apply to any such allotment. 
  

	8.	Merger or takeover 

 In the event that the Company is party to a merger, takeover or
other reorganisation including but not limited to a court sanctioned compromise or scheme arrangement, pursuant to which a party or parties acting in concert obtain(s) Control of the Company, or the Board consider that this is about to occur, or
notice is given of a resolution for the voluntary winding-up of the Company, the Board may, at its discretion with respect to the Option: 
  

	 	(a)	request the Optionholder to exercise the Option (in whole or in part) within such period as the Board may in its reasonable discretion determine (which shall not be less than ten days) and if the Optionholder does not
comply with such request, the Option shall lapse on a date specified by the Board; or 

  

	 	(b)	arrange for payment of a cash settlement to the Optionholder in cancellation of the Option equal per Share subject to the cancelled Option to the excess of the amount to be paid for a Share in the merger or takeover or
reorganisation or winding up over the Option Price. 

  

	9.	Restriction on Sale 

 In consideration of the Company entering into this Agreement, the
Optionholder agrees that notwithstanding the terms of the Articles of Association he shall not without the prior written consent of the Board: 
  

	 	(a)	offer for sale; 

  

	 	(b)	pledge; 

  

	 	(c)	sell; 

  

	 	(d)	contract to sell; 

  

	 	(e)	sell any option or contract to purchase; 

  

	 	(f)	grant any option, right or warrant to purchase; or 

  

	 	(g)	otherwise transfer or dispose of, directly or indirectly; 

 (and each such action shall be
referred to as a Sale for the purposes of this Clause 9), any Restricted Shares prior to the date that they become eligible for Sale in accordance with the following schedule: 

 

					
	 Date
	  	Percentage of Restricted Shares
Eligible for Sale	 
	 Prior to 1st anniversary of Grant Date
	  	 	0	% 
	 At any time on or after 1st anniversary of the Grant Date and before 2nd
Anniversary of the Grant Date
	  	 	25	% 
	 At any time on or after 2nd anniversary of the Grant Date and before 3rd Anniversary of the Grant Date
	  	 	Additional 25% (50% of total	) 
	 At any time on or after 3rd anniversary of the Grant Date
	  	 	Additional 50% (100% of total	) 

  
 5 

	10.	Liquidation 

 In the event of a liquidator being appointed to the Company the Option
shall ipso facto cease to be exercisable and (save to the extent, if at all, that the Board may prior to such liquidation at its absolute discretion determine) the Optionholder shall not be entitled to damages or other compensation of any kind. 

 

	11.	Consent to Data Processing 

 The Optionholder consents to the holding and processing of
personal data relating to him by the Company or any Associated Company for all purposes relating to the operation of this Agreement or his holding of any Shares, which purposes include but are not limited to: 

 

	 	(i)	administering and maintaining Optionholder records; 

  

	 	(ii)	providing information to tax and regulatory authorities; or 

  

	 	(iv)	providing information, on a confidential basis, to potential purchasers of the Company or the business in which the Optionholder is employed. 

 

	12.	General provisions 

  

	 	(a)	The rights of the Optionholder under this Agreement shall be deemed personal and shall not be assignable in whole or in part (except, upon the Optionholder’s death, to the Optionholder’s estate or other
transferee of such rights in accordance with the Optionholder’s will or as required by law) unless the Board in its sole discretion consents to an assignment or transfer. Any purported transfer, assignment, mortgage or charge of an Option
(except, upon the Optionholder’s death, to the Optionholder’s estate or other transferee of such rights in accordance with the Optionholder’s will or as required by law), without the consent in writing of the Board, shall cause the
Option to lapse forthwith. 

  

	 	(b)	If, in consequence of the grant, vesting, exercise, assignment or release of the Option, or the acquisition or disposal of Option Shares, the Company or any Associated Company has any obligation to account to the
relevant authorities for any liability to tax, levies, PRSI or health contribution or national insurance or social security contributions or duties of any kind, the relevant company shall be authorised to make such arrangements as it considers
necessary or appropriate to obtain the relevant sum of money from the Optionholder, to the extent permitted by law, and this shall include the authority to make a deduction or deductions from the basic salary of the Optionholder or to sell or
withhold Shares issued or issuable to the Option Holder on exercise of the Option. If withholding tax obligations arise in connection with any transaction under this Agreement, the Optionholder shall make arrangements satisfactory to the Company to
meet such obligations. The Company shall not be required to issue or allot any Shares until such obligations are satisfied. 

  

	 	(c)	Any notice given hereunder shall be in writing and shall be delivered or sent by pre-paid post to the address set out herein for the party to whom such notice shall have been addressed (or such other address as
designated from time to time to the other party hereto). 

  
 6 

	 	(d)	The section heading and captions to the clauses in this agreement are for reference only and shall not be considered a part of or affect the construction or interpretation of this agreement. 

 

	 	(e)	This agreement may be amended, modified, superseded or cancelled and any of its terms, covenants, representations, warranties, undertakings, or conditions may be waived only by a written instrument signed by (or by some
person duly authorised by) the parties or, in the case of a waiver, by the party waiving compliance. 

  

	 	(f)	This Agreement shall be governed by and construed in accordance with Irish law and the parties agree to submit to the exclusive jurisdiction of the Courts of Ireland in relation to any claim, dispute or difference which
may arise hereunder. 

  

	 	(g)	This Agreement shall enure to the benefit of and be binding upon the respective parties hereto and their respective successors and personal representatives. 

 

	 	(h)	This Agreement may be executed in any number of counterparts and by the different parties hereto on separate counterparts each of which when executed and delivered shall constitute an original all such counterparts
together constituting but one and the same instrument. 

 IN WITNESS whereof this Agreement has been entered into as a Deed on the day and
year first herein written. 

  
 7 

					
	 GIVEN under the common seal
 of TRINITY BIOTECH
PUBLIC LIMITED COMPANY
	 		 	
	and delivered as a deed	 		 	  

		 		 	Signature
			
		 		 	  

		 		 	Print Name
			
		 		 	  

		 		 	Signature
			
		 		 	  

		 		 	Print Name

  

					
	 SIGNED AND DELIVERED
 as a deed by WILLIAM J.
MAGGIO
	 		 	
	in the presence of:	 		 	  

		 		 	Signature
			
	  
	 		 	
	Witness (Signature)	 		 	
			
	  
	 		 	
	Print Name	 		 	
			
	  
	 		 	
	Print Address	 		 	
			
	  
	 		 	
	Witness Occupation	 		 	

  
 8 

 SCHEDULE 1 

Option Certificate 
 THIS DOCUMENT IS
IMPORTANT 
  

					
	Name:	  	 William J. Maggio
	  	
			
	Address:	  	 22 Linden Avenue
	  	
			
		  	 Buffalo NY 14214
	  	
			
		  	  
	  	
			
		  	  
	  	
			
	Grant Date:	  	 July     , 2013
	  	
			
	Number of Shares:	  	102,400 A Shares (25,600 ADRs)	  	
			
	Option Price per Share:	  	$1.66 per A Share ($6.64 per ADR).	  	
			
	Vesting Conditions:	  	 None (fully vested)
	  	
			
	Last Date on which Notice of Exercise of Option can be given:	  	 December 3, 2017
	  	

 THIS IS TO CERTIFY that the individual named above was on the above Grant Date granted an option to subscribe
for the above number of “A” Ordinary Shares (“Shares”) in Trinity Biotech plc (the “Company”) at the above Option Price per Share. This Option may not be transferred, assigned, mortgaged or charged by the Optionholder
in violation of the Option Agreement and any purported transfer, assignment, mortgage or charge will cause this Option to lapse forthwith. This Option is exercisable subject to and in accordance with the terms and conditions of the Option Agreement
dated the date hereof, a copy of which accompanies this Option Certificate. 
  

					
	 GIVEN under the common seal
 of TRINITY BIOTECH
PUBLIC LIMITED COMPANY
	 		 	
	and delivered as a deed	 		 	  

		 		 	Signature
			
		 		 	  

		 		 	Print Name
			
		 		 	  

		 		 	Signature
			
		 		 	  

		 		 	Print Name

  
 9 

 SCHEDULE 2 

Notice of Exercise of Option 
  

	To:	Trinity Biotech Public Limited Company 

 From: 

I hereby give notice of the exercise of an Option to subscribe for             “A”
Ordinary Shares in the capital of Trinity Biotech Public Limited Company granted to me under the Option Agreement dated [    ] July 2013. 

I enclose the Option Price of $         to acquire         “A”
Ordinary Shares. 
  

			
	Signed:	 	  

		
	Dated:	 	  

		
	Full Name:	 	  

		
	Address:	 	  

		
		 	  

		
		 	  

  
 10

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00229-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00229-of-00352.parquet"}]]